Search Results for “diagnostic” – Page 67 – media

Linda Healthcare Infuses A.I. and Blockchain to build Crypto Health Insurance

Over the past few years, more and more people have recognized the power of the blockchain to transform industries. In the over regulated, bureaucratic healthcare market, this is especially the case. Blockchain technology and innovative companies have the ability to revolutionize this market, create tremendous value, improve patient outcomes, create new treatments and pharmaceuticals while creating incredible companies that richly reward founders and management. Linda Health is one such company that is changing the market place with the blockchain. They have created a virtual medical assistant that is changing lives.
- Source: blockchainhealthcarereview
- 735
- December 1, 2017
blockchain ICO Researches
China makes use of AI for healthcare

An estimated 300 million Chinese people are smokers. China has also a serious issue with hazardous air pollution. Here concentrations of small, breathable particles (PM2.5) invariably exceeding 300 micrograms per cubic meter in the industrialized northern regions.
- Source: digitaljournal
- 653
- November 23, 2017
Artificial Intelligence China healthcare lung cancer
Japan’s PeptiDream Bags $1.11B+ R&D Pact With Bayer

Peptidream Inc. has scored another billion dollar-plus agreement to develop peptide-based therapies aimed at the treatment multiple disease targets.
- Source: Biospace
- 505
- November 21, 2017
Market Views PDC PDPS peptide-based
Bristol-Myers, J&J sink cash into a new $95M European biotech fund

A venture capital firm in the Netherlands — backed by some big names in Big Pharma — has raised $95 million in a new fund to fuel European biotech startups.
- Source: Endpts
- 616
- November 3, 2017
diagnostics funding Market Views medical device therapeutics
Wearable Devices–A New Look For The Modern Clinical Trial

Clinical development has historically been a laborious and expensive process that stretches across all therapeutic areas. It is driven by lengthy patient recruitment timelines, increasingly complex study designs, and high procedural costs. Depending on whose data you believe, getting a new drug to market can now cost upwards of $1 billion and take more than 10 years or research and development effort. Additionally, a complex and dynamic regulatory framework has made sponsors reluctant to introduce new technologies to facilitate the development process.
- Source: clinicalleader
- 987
- November 2, 2017
Artificial Intelligence Clinical machine learning Researches wearables
New Use of A.I. Accurately Detected Cancer 86 Percent of the Time

The quest to better detect cancer has made a potentially huge strides. A study out of Yokohama, Japan, has potentially harnessed artificial intelligence to help detect colorectal cancer even before benign tumors become malignant.
- Source: inverse
- 723
- November 1, 2017
Artificial Intelligence colorectal cancer Market Views
WHO report signals urgent need for greater political commitment to end tuberculosis

Global efforts to combat tuberculosis (TB) have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37%, according to the Global TB Report 2017, released by WHO today.
- Source: who
- 597
- October 31, 2017
Market Views tuberculosis WHO
University of Texas to develop cheap at-home test for heart failure

A research team at the University of Texas, US, is set to develop an affordable at-home diagnostic test for patients with heart failure.
- Source: medicaldevice-network
- 796
- October 16, 2017
diagnostic heart Researches
Roche secures FDA approval for Zika virus screening test

Roche has secured approval from the US Food and Drug Administration (FDA) for its cobas Zika test to detect RNA of the Zika virus in human plasma samples.
- Source: medicaldevice-network
- 680
- October 11, 2017
FDA New Approvals plasma Zika
FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration

The U.S. Food and Drug Administration(FDA) approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip (often referred to as a “fingerstick”).
- Source: fda.gov
- 838
- September 30, 2017
FDA Glucose Monitoring System New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.